Renal Damage in Rats from the Lead Salt of EDTA and from Umbradil®

Alvall N. Johnsson S. Tornberg A. Werkö L. : Acute renal failure following angiography, especially the risk of repeated examination, revealed by eight cases (two deaths). Acta chir. scandinav. 109(1955), 111.

Bauer R. O. Rullo F. R. Spooner Ch. Woodman E. : Acute and subacute toxicity of ethylene diamine tetraacetic acid (EDTA) salts. Fed. Proc. 11(1952), 321.

Bessman S. P. Reid H. Rubin M. : Treatment of lead encephalopathy with calcium versenate. Med. Ann. Distr. Columbia 21(1952), 312.

Carlström D. : X-ray crystallographic studies on apatites and calcified structures. Acta radiol. Suppl. 121(1955).

Clark B. J. Tomich E. G. : Pharmacological studies on lead E. D. T. A. British Med. J. (1955), p. 831.

Fajers C. M. : On the effect of brief unilateral renal ischemia. Acta path. microbiol. scand. Suppl. 106(1955).

Foreman H. : The use of chelating agents for accelerating excretion of radio-elements. J. Amer. Pharm. Ass. (Scient. ed.) 42(1953), 629.

Rubin M. : Chelation, key to metal ion control. Drug and Cosmetic Ind. 74(1954), 496.

Gignac S. Bessman S. P. Belknay E. L. : Enhancement of lead excretion in humans by disodium calcium ethylene diamine tetraacetate. Science 117(1953), 659.

Sapeika N. : Lead EDTA complex. A watersoluble contrast medium. Sth. Afr. med. J. 28(1954), 759.

Tjernberg B. : Roentgenographic and toxicologic studies on lead EDTA. Acta radiol. 47(1957), 308.